NCT00557609 2013-02-08Phase 2 Study in Patients With MiT TumorsArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)Phase 2 Completed47 enrolled